Inventor · disambiguated record

Gabriel Martinez Botella

Also filed as: MARTINEZ BOTELLA GABRIEL

83 granted patents·54 pending applications·772 citations·filing 2010–2025

99Inventor score

Technology areasA61P C07J A61K C07D C07B

Files withSAGE THERAPEUTICS INC98 PRAXIS PREC MEDICINES INC35 VERTEX PHARMA2 HARRISON BOYD L1 LEDEBOER MARK1

Top patents by PatentIndex Score

137 records

0199US11530237B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·9 cites·4 claims
0299US11149057B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Oct 19, 2021·9 cites·33 claims
0399US10723758B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·20 cites·2 claims
0499US10246482B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·38 cites·85 claims
0598US11905309B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·5 cites·18 claims
0698US11878995B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·5 cites·16 claims
0798US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
0898US11542297B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·9 cites·28 claims
0998US11279700B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Mar 22, 2022·13 cites·20 claims
1098US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
1198US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
1298US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
1398US11104701B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·16 cites·24 claims
1498US11014931B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2020·Granted May 25, 2021·18 cites·18 claims
1598US10870677B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·13 cites·1 claims
1698US10696712B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·21 cites·3 claims
1798US10259840B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 16, 2019·30 cites·3 claims
1898US10227375B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·33 cites·4 claims
1998US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
2097US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
2197US11884697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·6 cites·27 claims
2297US11780875B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·4 cites·20 claims
2397US11732000B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·6 cites·12 claims
2497US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
2597US11407782B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·5 cites·22 claims
2697US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
2797US10745436B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·9 cites·30 claims
2897US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
2997US10201550B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·23 cites·2 claims
3097US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
3197US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
3297US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
3396US12129276B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·2 cites·20 claims
3496US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
3596US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
3696US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
3796US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
3896US11147877B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Oct 19, 2021·8 cites·12 claims
3996US11046728B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·8 cites·14 claims
4095US12268697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·1 cites·4 claims
4195US12180247B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·2 cites·12 claims
4295US11773088B2KCNT1 inhibitors and methods of usePRAXIS PREC MEDICINES INC·Filed 2021·Granted Oct 3, 2023·3 cites·19 claims
4395US11731978B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2022·Granted Aug 22, 2023·2 cites·4 claims
4495US11261188B2Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channelPRAXIS PREC MEDICINES INC·Filed 2017·Granted Mar 1, 2022·11 cites·16 claims
4595US10329320B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 25, 2019·18 cites·25 claims
4694US12473327B2Neuroactive steroids, compositions and uses thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Nov 18, 2025·1 cites·16 claims
4794US10577390B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Mar 3, 2020·10 cites·3 claims
4894US10323059B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·12 cites·7 claims
4993US11767325B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Sep 26, 2023·3 cites·16 claims
5093US11731976B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2021·Granted Aug 22, 2023·2 cites·30 claims

Showing the top 50 of 137 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Gabriel Martinez Botella files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →